ORI found that Yiorgos (Georgios) I. Laliotis, M.D. , who was a Postdoctoral Fellow, Department of Cancer Biology and Genetics, College of Medicine, OSU, and Postdoctoral Fellow, Department of Oncology, JHU, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), and included in grant applications for PHS funds submitted to NCI, NIH.